Daniel Olson

13PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 22, 2026
Tumor-infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions.

|Nov 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.

Benjamin T Cooper, Wade T Iams, David B Page

|Mar 28, 2024
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers 2022, 14, 2458.

Robin Reschke, Daniel J Olson

|Apr 27, 2023
Adoptive Cell Therapy for Nonhematologic Solid Tumors.

Daniel J Olson, Kunle Odunsi

|Feb 01, 2023
Team Approach: Management of Pathologic Fractures.

Aws Hammad, Osman Ahmed, Philip P Connell

|Jan 19, 2023
Myeloid Maturity: ATRA to Enhance Anti-PD-1?

Daniel J Olson, Jason J Luke

Pageof 3

Frequent Collaborators

3 joint publications

Robin Reschke

3 joint publications

Jason J Luke

2 joint publications

Sherin Juliet Rouhani

2 joint publications

Jovian Yu